
We reviewed new psoriatic arthritis approvals as well as data readouts from head-to-head trials and milestone data in IgG4-related disease.
Men are more likely to stay the course of TNF inhibitor therapy.
Reference1. Rusman T, Ten Wolde S, Euser SM, et al. Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice. Int J Rheum Dis. 2018;21:836-842. doi: 10.1111/1756-185X.13271.